(+)-Usnic acid and its salts, inhibitors of SARS-CoV-2, identified by using in silico methods and in vitro assay(+)-Usnic acid 및 그 염, SARS-CoV-2 억제제, in silico 방법 및 시험관 내 분석을 사용하여 확인Article Published on 2022-07-302022-09-11 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제, [키워드] anti-SARS-CoV-2 Antiviral Beta variant beta variants calculated caused compounds continuum COVID-19 COVID-19 treatment database Efficacy immunofluorescence In silico method in vitro in vivo inhibitors inhibitors of SARS-CoV-2 investigated molecular molecular dynamics monoclonal antibodies Mpro protein pandemic positive control Protein target protein-ligand interaction Remdesivir required RMSD SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 variants selectivity index severe acute respiratory coronavirus Severe acute respiratory coronavirus-2 sodium surface area targets Treatment treatment for COVID-19 usnic acid Virtual screening was performed was selected [DOI] 10.1038/s41598-022-17506-3 PMC 바로가기 [Article Type] Article
Analysis of multi-strain infection of vaccinated and recovered population through epidemic model: Application to COVID-19전염병 모델을 통한 예방접종 및 회복된 인구의 다중 균주 감염 분석: COVID-19에 적용Article Published on 2022-07-292022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, [키워드] analyzed application assumed calculated condition COVID-19 COVID-19 virus Delta dissemination Endemic Epidemic greater herd immunity Herd immunity threshold immune Infection Infectious disease investigated multi Mutation omicron Omicron variants question Reproduction number Spread stability state strain Strains susceptible the disease Vaccine Validity variant variants viral strains [DOI] 10.1371/journal.pone.0271446 PMC 바로가기 [Article Type] Article
Urtica dioica Agglutinin: A plant protein candidate for inhibition of SARS-COV-2 receptor-binding domain for control of Covid19 InfectionUrtica dioica Agglutinin: Covid19 감염 통제를 위한 SARS-COV-2 수용체 결합 도메인 억제를 위한 식물성 단백질 후보Article Published on 2022-07-282022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 유전자 메커니즘, 진단, [키워드] ACE2 addition angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme-2 Antiviral effect average bind binding binding affinity binding energy binding free energy binding site calculated Cell complex convalescent serum coronavirus docked docking docking result docking results domain Donor donors dynamic effective effective drug effective drugs ELISA ELISA assay enzyme exhibited free energy Gromacs host cell human cells IgG Infection inhibit inhibitory activity Interaction limitation MD simulation mechanism Medicine Medicines MTT Mutation peptide Prevent Previous studies Protein RBD RBD binding RBD complex RBD protein Receptor-binding domain Result S-protein Safe SARS-CoV SARS-CoV-2 Simulation spike Spike protein spike protein of SARS-CoV-2 stability the cell the RBD Toxicity Urtica Vaccine virus was performed was used [DOI] 10.1371/journal.pone.0268156 PMC 바로가기 [Article Type] Article
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay살아있는 바이러스 SARS-CoV-2 중화 분석의 최적화 및 평가Article Published on 2022-07-282022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료법, [키워드] 24 hour 24 hours acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 added antibody application calculated cell monolayer cell suspension cells clinical isolates Coefficient of variance coronavirus correlated correlation Critical described dose ELISA enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay evaluated functional antibody response functional antibody responses growth immune evasion Immunity include Incubation period infecting Influenza Influenza virus inoculation isolates Live virus microneutralization neutralization Neutralization assay neutralization titers nucleocapsid protein optimization parameter Post-infection Precision protein level reduced replicating virus respiratory SARS-CoV-2 SARS-CoV-2 clinical isolate SARS-CoV-2 clinical isolates SARS-CoV-2 microneutralization assay SARS-CoV-2 neutralization severe acute respiratory syndrome Coronavirus the SARS-CoV-2 the strongest therapeutic Vaccine variance Vero E6 Vero E6 cell VERO E6 cells Viral Viral variants virus virus infection virus inhibition virus inoculum virus neutralization assays Virus titration was determined WHO [DOI] 10.1371/journal.pone.0272298 PMC 바로가기 [Article Type] Article
Efficacy and effectiveness of SARS-CoV-2 vaccines for death prevention: A protocol for a systematic review and meta-analysis사망 예방을 위한 SARS-CoV-2 백신의 효능 및 효과: 체계적인 검토 및 메타 분석을 위한 프로토콜Article Published on 2022-07-282022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), MERS, meta-analysis, SARS, [키워드] adverse event all-cause mortality analyzed approved assessment Bia calculated case-control studies case-control study Cohort controlled trials COVID-19 death deaths effective Effectiveness Efficacy Egger eligible Evidence exploratory for inclusion forest plot forest plots funnel plot hazard hazard ratios heterogeneity Hospitalization incident independent intervals Intervention Meta-analysis Mortality Observational data outcome Placebo Prevent Primary outcome PROSPERO protocol Publication bia publication bias randomized control trial Randomized controlled trials RCT Record reducing Registered risk reduction SARS-CoV-2 vaccine SARS-CoV-2 vaccines Secondary outcomes Severe case severe cases statistical statistical test systematic review the vaccine the vaccines university vaccination Vaccination Status Vaccine visual inspection York [DOI] 10.1371/journal.pone.0265414 PMC 바로가기 [Article Type] Article
Sero-prevalence and risk factors for Severe Acute Respiratory Syndrome Coronavirus 2 infection in women and children in a rural district of Bangladesh: A cohort study방글라데시 농촌 지역 여성과 어린이의 중증 급성 호흡기 증후군 코로나바이러스 2 감염에 대한 혈청 유병률 및 위험 요인: 코호트 연구Article Published on 2022-07-232022-09-12 Journal: Journal of Global Health [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] 95% CI 95% confidence interval addition adjusted relative risk age Asymptomatic baseline behavioural interventions calculated Care children cohort study collected collected data collecting data Comorbidities conducted confirmed case contribute coronavirus 2 Course COVID-19 COVID-19 case COVID-19 knowledge deaths Factor feasible group groups highest identify Infection lockdown lower risk lowest Mild MOST pandemic participant provided regression models reported respiratory risk risk factor risk of infection SARS-CoV-2 antibodies SARS-CoV-2 antibody seropositive tested women [DOI] 10.7189/jogh.12.05030 PMC 바로가기 [Article Type] Article
Psychometric properties of the Spanish version of the EuroQol-5D-5L in previously hospitalized COVID-19 survivors with long COVID Research Published on 2022-07-232022-10-05 Journal: Scientific Reports [Category] 치료법, [키워드] 95%CI Alpha Analysis calculated coefficient construct validity COVID COVID-19 Cronbach’s alpha Effect hospital discharge Hospitalized hospitalized COVID-19 individual internal internal consistency long-COVID Omega outcome measure psychometric property Quality of life questionnaire ranged reliability Spanish survivor Symptom total score [DOI] 10.1038/s41598-022-17033-1 [Article Type] Research
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung diseaseClinical Trial Published on 2022-07-232022-10-05 Journal: Orphanet Journal of Rare Diseases [Category] COVID19(2023년), SARS, 임상, [키워드] absence adverse event age all subject approval ARMS calculated Child childhood children Controlled trial double-blind effect size Endpoint evaluated four subject groups HCQ Health Hydroxychloroquine identify Interstitial lung disease Interstitial lung diseases lack lung Lung function multicentre Munich not differ not different offered outcome Oxygenation participated phase 2 trial Placebo placebo-controlled primary endpoint Pulmonary function Quality of life Randomized randomized-controlled trial Registered Registration respiratory rate Respiratory Support secondary study population subject Treatment treatment effects treatment period Trial university were given Withdrawal [DOI] 10.1186/s13023-022-02399-2 PMC 바로가기 [Article Type] Clinical Trial
BNT162b2 Vaccine Effectiveness against Omicron in Children 5 to 11 Years of Age5~11세 어린이의 오미크론에 대한 BNT162b2 백신 효과Article Published on 2022-07-212022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, 진단, 치료법, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age BNT162b2 BNT162b2 vaccine calculated Care children Cohort Control controls coronavirus coronavirus disease Coronavirus disease 2019 cumulative cumulative incidence dominant variant dose Effectiveness eligible European event Evidence first dose Health Health care incidence Infection Kaplan-Meier estimator Limited Messenger RNA moderate of BNT162b2 omicron Omicron variant outcome provided risk risk difference risk ratio RNA vaccine SARS-CoV-2 SARS-COV-2 infection second dose severe acute respiratory syndrome Coronavirus study group study groups study period subgroups symptomatic COVID-19 the study group the vaccine union Vaccine vaccine doses Year [DOI] 10.1056/NEJMoa2205011 PMC 바로가기 [Article Type] Article
Long-term cognitive functioning is impaired in ICU-treated COVID-19 patients: a comprehensive controlled neuropsychological studyArticle Published on 2022-07-202022-10-05 Journal: Critical Care [Category] 임상, [키워드] acute COVID-19 acute phase calculated Care carried cognitive Cognitive functioning Cognitive impairment cohort study collected Control control group controls coronavirus disease COVID-19 COVID-19 patients demographic data depressive domain effect size electronic patient record executive function functions group Helsinki hypothesised ICU impairment information intensive care intensive care unit less long-term outcome male measure memory men outcome participant Patient patients performed post-traumatic provided Registered Symptoms three group university [DOI] 10.1186/s13054-022-04092-z PMC 바로가기 [Article Type] Article